The Effect of HIV and Antiretroviral Therapy on Drug-Resistant Tuberculosis Treatment Outcomes in Eastern Cape, South Africa: A Cohort Study
South Africa has a dual high burden of HIV and drug-resistant TB (DR-TB). We sought to understand the association of HIV and antiretroviral therapy status with TB treatment outcomes. This was a retrospective chart review of 246 patients who began treatment at two DR-TB hospitals in Eastern Cape, Sou...
Main Authors: | Brittney van de Water, Nadia Abuelezam, Jenny Hotchkiss, Mandla Botha, Limpho Ramangeola |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-11-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/15/11/2242 |
Similar Items
-
Training, guideline access and knowledge of antiretroviral interactions: Is the South African private sector being left behind?
by: BS Chisholm, et al.
Published: (2022-10-01) -
Barriers to access to antiretroviral treatment for HIV-positive tuberculosis patients in Windhoek, Namibia
by: Stefanie Seeling, et al.
Published: (2014-01-01) -
Tuberculosis associated mortality in a prospective cohort in Sub Saharan Africa: Association with HIV and antiretroviral therapy
by: Tumaini J. Nagu, et al.
Published: (2017-03-01) -
Pharmacokinetics of Efavirenz 600mg in Combination with Rifampicin in Chinese HIV/TB Co-Infection Patients
by: Wang T, et al.
Published: (2023-07-01) -
Pharmacokinetic interactions between rifampicin and efavirenz in HIV-TB coinfections
by: Yenny
Published: (2009-12-01)